Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added and updated the results section for NCT03230318, including primary and secondary outcomes (ORR, PFS, OS, DoR) and safety data (TEAEs). Updated primary completion and study completion dates.
    Difference
    0.1%
    Check dated 2026-01-07T02:01:56.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    No significant changes detected in the Study Details page; the content, including eligibility criteria and outcome measures, remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-31T00:02:03.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now presents a consolidated 'Locations' section with listed sites (Arizona, Florida, Georgia, Minnesota, New York, Pennsylvania, Tennessee, Texas, Washington, Alberta, Ontario) and removes the prior per-state headers (e.g., 'Arizona Locations'). The revision has been updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T22:53:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The new screenshot shows a layout refresh while preserving all core study details (title, brief summary, eligibility criteria, outcomes, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-16T22:03:04.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The updates appear to be cosmetic adjustments to the page layout (header alignment, spacing, and navigation) with no changes to core study content, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-09T19:31:52.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    No additions or deletions to core study content detected; observed differences appear to be minor visual/layout changes in the page rendering.
    Difference
    0.1%
    Check dated 2025-12-02T17:35:38.000Z thumbnail image

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.